We introduce a mathematical model that can detect differential selection pressure, which is validated in CBFB-MYH11-positive acute myeloid leukemia (AML) to confer superior prognostic value on event-free survival (EFS) than other well-known clinical features. The gene discussed is CBFB; the disease is acute myeloid leukemia.